Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease

European Journal of Clinical Investigation

Volumn 31, Issue 2, 2001, Pages 131-137

  Muller B ^a   Tsakiris, D A ^a   Roth, C B ^a   Guglielmetti, M ^a   Staub, J J ^a   Marbet, G A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Factor VII; Hypercoagulable state; Subclinical hypothyroidism; Von Willebrand factor

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; ESTROGEN; FIBRINOGEN; HEPARIN COFACTOR II; LIPID; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN C; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPOTHYROIDISM; ISCHEMIC HEART DISEASE; MEASUREMENT; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK FACTOR; THROMBOEMBOLISM; THYROID FUNCTION; VASCULAR DISEASE;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CORONARY THROMBOSIS; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RISK FACTORS;

EID: 0035106201     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00777.x     Document Type: Article

References (44)

1. The spectrum of thyroid disease in a community: The Whickham survey
2. LDL/HDL-changes in subclinical hypothyroidism: Possible risk factors for coronary heart disease
3. Preclinical hypothyroidism: A risk factor for coronary heart-disease
4. Raised serum thyrotrophin in women with peripheral arterial disease
5. Spectrum of subclinical and overt hypothyroidism: Effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues
6. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease?
7. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study
8. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men
9. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
10. Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis
11. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
12. Serum-derived growth factor is thrombin?
13. Haemorrhage in myxoedema coma
14. Haemostasis in hypothyroidism
15. Primary, haemostasis in thyroid disease
16. Hypothyroidism as a cause of acquired von Willebrand's disease
17. Is a hypercoagulable state present in hypothyroidism?
18. Relationship between thyroid hormones and plasma D-dimer levels
19. Relationship between thyroid hormones and fibrinogen levels
20. Coagulation disorders in thyroid diseases
21. Impaired action of thyroid hormone associated with smoking in women with hypothyroidism
22. Analytische methoden
23. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population - II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions
24. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction - The PRIME Study. Prospective Epidemiological Study of Myocardial Infarction
25. Factor VIII activity and thyroid function
26. Hypothyroidism: Diversity of presentation
27. Metabolism of the coagulation factors of the prothrombin complex in hypothyroidism in man
28. The biological disappearance rate of prothrombin, factor VII, IX and X from plasma in hypothyroidism, hyperthyroidism and during fever
29. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables
30. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
31. Plasma factor VIIa: Measurement and potential clinical significance
32. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease
33. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives
34. Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives
35. Regulation of the procoagulant response to arterial injury
36. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
37. Coagulation factor VII and the risk of coronary, heart disease in healthy men
38. Determinants of population changes in fibrinogen and factor VII over 6 years: The Atherosclerosis Risk in Communities (ARIC) Study
39. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: Results from the cardiovascular health study
40. Low free-thyroxine levels are a risk factor for subclinical atherosclerosis in euthyroid hyperlipidemic patients
41. Hormone therapy to prevent disease and prolong life in postmenopausal women
42. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study
43. Cardiovascular disease risk and hormone replacement therapy (HRT): A review based on randomised, controlled studies in postmenopausal women